Syncom Formulations is trading at INR 23.55, 5.57% down on October 8, with no clear company-specific catalyst found. - The previous session closed at INR 24.94, up 7.41%, on reported volume of 40,579,546 shares. - Available coverage points to earlier AGM approvals and director appointments, not a new announcement explaining the decline. - The evidence does not establish why the price reversed; a pullback after the previous session’s gain is possible but unconfirmed.